Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. GenOway
  6. News
  7. Summary
    ALGEN   FR0004053510

GENOWAY

(ALGEN)
  Report
SummaryQuotesChartsNewsCalendarCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

GenOway Société anonyme announced that it expects to receive €5 million in funding from NextStage AM

05/05/2021 | 06:00pm EST

genOway Société anonyme (ENXTPA:ALGEN) announced a private placement 1,250,000 common shares at an issue price of €4 per share for gross proceeds of about €5,000,000 on May 6, 2021. The transaction will include participation from institutional investors and company executives.


© S&P Capital IQ 2021
All news about GENOWAY
10/26GLOBAL MARKETS LIVE : Michelin, Facebook, UBS, Tesla, Volvo...
09/27Genoway Société Anonyme Reports Earnings Results for the Half Year Ended June 30, 2021
CI
05/27GenOway Société anonyme announced that it has received €5.6 million in funding from Nex..
CI
05/05GenOway Société anonyme announced that it expects to receive €5 million in funding from..
CI
04/30Genoway Soci?T? Anonyme Reports Earnings Results for the Full Year Ended December 31, 2..
CI
2020Genoway S.A. Reports Earnings Results for the Half Year Ended June 30, 2020
CI
2020GenOway S.A. announced that it has received €1.7 million in funding from Eximium SAS, D..
CI
2020GENOWAY : and Merck Strengthen CRISPR/Cas9 Strategic Alliance by Extending Their Partnersh..
AQ
2019GENOWAY : The Institut Pasteur and Cellectis extend exclusive license rights by granting g..
PU
2018Merck and genOway Form CRISPR/Cas9 Strategic Alliance to Develop Rodent Models
CI
More news
Financials
Sales 2020 16,3 M 18,4 M 18,4 M
Net income 2020 -0,69 M -0,78 M -0,78 M
Net Debt 2020 8,05 M 9,10 M 9,10 M
P/E ratio 2020 -
Yield 2020 -
Capitalization 39,9 M 45,0 M 45,1 M
EV / Sales 2019 0,88x
EV / Sales 2020 1,81x
Nbr of Employees 121
Free-Float 86,5%
Chart GENOWAY
Duration : Period :
genOway Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends GENOWAY
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Managers and Directors
Christian Grenier Chairman & Chief Executive Officer
Benjamin Bruneau Chief Financial Officer
Alexandre Fraichard Chief Operating Officer & Director
Robert Léon Director
Andre Tartar Director
Sector and Competitors
1st jan.Capi. (M$)
GENOWAY46.45%46
MODERNA, INC.188.59%122 239
LONZA GROUP AG25.98%57 878
IQVIA HOLDINGS INC.46.64%50 192
SEAGEN INC.-9.40%29 014
CELLTRION, INC.-41.36%24 745